Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Critical Illness | 14 | 2021 | 17281 | 0.90 | Why? |
| Sodium Chloride | 2 | 2018 | 203 | 0.75 | Why? |
| Intensive Care Units | 16 | 2021 | 29594 | 0.75 | Why? |
| Chlorides | 1 | 2018 | 82 | 0.71 | Why? |
| Tracheitis | 1 | 2018 | 43 | 0.70 | Why? |
| Fluid Therapy | 3 | 2017 | 628 | 0.68 | Why? |
| Bronchitis | 1 | 2018 | 146 | 0.64 | Why? |
| Albumins | 1 | 2018 | 324 | 0.62 | Why? |
| Cloud Computing | 1 | 2018 | 214 | 0.61 | Why? |
| Pulmonary Alveoli | 1 | 2019 | 867 | 0.53 | Why? |
| Azithromycin | 4 | 2020 | 3943 | 0.51 | Why? |
| Resuscitation | 1 | 2018 | 638 | 0.48 | Why? |
| Hydroxychloroquine | 5 | 2021 | 12447 | 0.44 | Why? |
| Positive-Pressure Respiration | 1 | 2019 | 1160 | 0.42 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2018 | 861 | 0.40 | Why? |
| Brazil | 12 | 2021 | 12582 | 0.40 | Why? |
| Frailty | 2 | 2018 | 1432 | 0.39 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.38 | Why? |
| Hospital Mortality | 10 | 2021 | 22087 | 0.33 | Why? |
| Acute Kidney Injury | 2 | 2018 | 5762 | 0.33 | Why? |
| Sepsis | 2 | 2020 | 3517 | 0.29 | Why? |
| Critical Care | 5 | 2020 | 14081 | 0.29 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.28 | Why? |
| Machine Learning | 1 | 2019 | 4395 | 0.24 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.24 | Why? |
| Respiration, Artificial | 7 | 2021 | 22116 | 0.24 | Why? |
| Bayes Theorem | 3 | 2020 | 3237 | 0.23 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.21 | Why? |
| Sodium Acetate | 1 | 2017 | 3 | 0.18 | Why? |
| Magnesium Chloride | 1 | 2017 | 4 | 0.18 | Why? |
| Potassium Chloride | 1 | 2017 | 24 | 0.17 | Why? |
| Gluconates | 1 | 2017 | 28 | 0.17 | Why? |
| Deep Sedation | 1 | 2019 | 121 | 0.17 | Why? |
| Critical Care Outcomes | 1 | 2018 | 138 | 0.17 | Why? |
| Infusions, Intravenous | 2 | 2021 | 1224 | 0.16 | Why? |
| Logistic Models | 3 | 2019 | 9089 | 0.14 | Why? |
| Spatial Analysis | 1 | 2020 | 878 | 0.14 | Why? |
| Registries | 3 | 2020 | 12327 | 0.14 | Why? |
| Research Design | 3 | 2020 | 5830 | 0.13 | Why? |
| Benchmarking | 1 | 2017 | 627 | 0.13 | Why? |
| Humans | 33 | 2021 | 930598 | 0.13 | Why? |
| Checklist | 1 | 2019 | 714 | 0.12 | Why? |
| Drug Therapy, Combination | 3 | 2020 | 7268 | 0.12 | Why? |
| Critical Care Nursing | 1 | 2018 | 469 | 0.12 | Why? |
| HLA-A Antigens | 1 | 2013 | 196 | 0.11 | Why? |
| Frail Elderly | 2 | 2018 | 1427 | 0.11 | Why? |
| Anti-Inflammatory Agents | 2 | 2021 | 6153 | 0.11 | Why? |
| Aged | 13 | 2021 | 215776 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Cluster Analysis | 1 | 2019 | 3001 | 0.10 | Why? |
| Adult | 15 | 2021 | 244371 | 0.10 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.10 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.10 | Why? |
| Dexamethasone | 1 | 2020 | 2055 | 0.09 | Why? |
| Length of Stay | 4 | 2020 | 11042 | 0.09 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.09 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.09 | Why? |
| Health Care Surveys | 1 | 2018 | 2942 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Health Resources | 2 | 2018 | 2592 | 0.09 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.09 | Why? |
| Clinical Protocols | 1 | 2019 | 2734 | 0.09 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Perioperative Care | 1 | 2018 | 1329 | 0.08 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2021 | 10649 | 0.08 | Why? |
| Cause of Death | 2 | 2021 | 4823 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.08 | Why? |
| Stroke Volume | 1 | 2017 | 2153 | 0.08 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.08 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.08 | Why? |
| Hemodynamics | 1 | 2014 | 1562 | 0.07 | Why? |
| Administration, Intravenous | 2 | 2020 | 1115 | 0.07 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Nursing Staff, Hospital | 1 | 2018 | 1554 | 0.07 | Why? |
| Female | 13 | 2021 | 380317 | 0.07 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Male | 12 | 2021 | 367725 | 0.06 | Why? |
| Shock, Septic | 1 | 2013 | 1313 | 0.06 | Why? |
| Tidal Volume | 2 | 2017 | 565 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Burnout, Professional | 1 | 2018 | 2489 | 0.06 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.06 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Simplified Acute Physiology Score | 1 | 2019 | 102 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Pharmaceutical Solutions | 1 | 2018 | 24 | 0.05 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.05 | Why? |
| Genetic Predisposition to Disease | 1 | 2013 | 4027 | 0.05 | Why? |
| Sample Size | 1 | 2021 | 518 | 0.05 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2020 | 1256 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Water-Electrolyte Imbalance | 1 | 2018 | 119 | 0.04 | Why? |
| Conscious Sedation | 1 | 2019 | 222 | 0.04 | Why? |
| Catheter-Related Infections | 1 | 2020 | 381 | 0.04 | Why? |
| Drug Compounding | 1 | 2018 | 386 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Patient Reported Outcome Measures | 1 | 2021 | 912 | 0.04 | Why? |
| Return to Work | 1 | 2021 | 579 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.03 | Why? |
| Patient Participation | 1 | 2021 | 829 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Hypnotics and Sedatives | 1 | 2019 | 624 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2019 | 1475 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Telephone | 1 | 2021 | 1705 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Respiration | 1 | 2017 | 729 | 0.03 | Why? |
| Patient Readmission | 1 | 2021 | 1543 | 0.03 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.03 | Why? |
| Haplotypes | 1 | 2013 | 853 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Hemorrhage | 1 | 2021 | 3013 | 0.02 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.02 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Biomarkers | 1 | 2013 | 23361 | 0.01 | Why? |
Zampieri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(433)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_